The importance of CD8+ T cells in hRT/lena-mediated abscopal tumor control was confirmed by analysis of single-cell suspensions of tumors and TDLNs of B16-CD133 tumor-bearing mice at day 8 after treatment start using flow cytometry (Figure 2D). Here, CD8A is linked to neoplasm.